By Iain Gilbert
Date: Monday 13 May 2024
(Sharecast News) - Life sciences business Aptamer said on Monday that its current sales pipeline was "strong", with over £3.0m in advanced stage discussions.
Aptamer said a proportion of these advanced-stage deal negotiations were anticipated to progress through its laboratory before the end of the financial year, with the anticipated deal...
or login to read the full story
Email this article to a friend
or share it with one of these popular networks:
You are here: news